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Photodynamic therapy (PDT) is widely used to treat superficial non-melanoma skin cancers 
and dysplasia.1  Pain may be experienced during irradiation, with one study showing pain 
intervention was required in 44% of PDT treatments.2  Other retrospective studies indicated 
that large treatment areas on head and neck sites, actinic keratoses and strong 
protoporphyrin IX fluorescence may be predictors of more severe PDT-induced pain, but 
data were not conclusive.3,4  Excepting nerve blockade or reduction in irradiance, other pain 
relief methods are relatively ineffective. It is therefore important to identify predictors of PDT-
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induced pain to better inform patients and practitioners. We aimed to identify patient or 
lesion characteristics or aspects of treatment that were associated with PDT-induced pain 
and treatment outcomes at one year, in patients with superficial basal cell carcinomas 
(sBCC) and Bowen’s disease (BD).   
The study was undertaken in the Scottish PDT Centre. Caldicott Guardian Approval was 
granted.  Data relating to patient, lesion, treatment parameters and outcomes were retrieved 
from the dedicated in-house PDT database and, when necessary, from PDT case notes.  
Patients included in the study were those who commenced topical methyl aminolevulinate 
(Metvix®) PDT between 01.01.11 and 31.12.13 for a diagnosis of sBCC and/or BD. The 
treatment regimen that was used employed gentle surface preparation and a three hour 
Metvix® application time, followed by red LED irradiation (predominantly Aktilite; 
approximately 85 mW/cm2; 75 J/cm2). Treatment was repeated at one week to complete the 
treatment cycle and clinical assessment and follow-up was undertaken at three months, with 
a repeat treatment cycle at that stage if there was evidence of residual disease. Follow-up to 
one year after last PDT treatment was undertaken. Endpoints were assessed as per our 
routine PDT clinic practice.  
Pain was assessed using VAS scores immediately after PDT irradiation (0-10cm).  
Fluorescence was graded visually using a standard Wood’s light examination (0-3 for none, 
weak, moderate, strong fluorescence) and erythema was also graded visually by naked eye 
examination (0-3 for none, mild, moderate, severe erythema) using these semi-quantitative 
scales and clinical outcome (no response, partial or complete clearance) was assessed at 
follow-up >10 months after treatment completion (defined as one-year outcome).  Data from 
the first treatment for pain, fluorescence and erythema were used and were assessed by 
linear regression models for the continuous outcome variable of pain and logistic regression 
for the binary outcome of clear or not clear at one year. In these models “clustering” by 
patient was taken into account, recognising that lesions within an individual should not be 
considered to be independent. Various exploratory multivariate analyses were conducted: 
the final models for pain included all factors significant at p<0.1 on univariate analyses, 
including fluorescence, erythema, gender and an interaction term for fluorescence and 
erythema. The assumptions for the models used (for example, normal distribution of 
residuals and constant variance of residuals for linear regression) were checked. Stata 
(Stata Corp., Texas, 2015) was used.  
Data relating to 173 lesions in 74 patients were included.  The median (range) age was 75 
(40-100) years and 63% of lesions were in women.  Of the lesions, 46% were sBCC, with a 
median diameter of 1.4 (0.3-10) cm and 95% one-year clearance.  The remaining 54% were 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
BD, with a median diameter of 1.3 (0.2-10) cm and 93% one-year clearance.  Most lesions in 
women were on lower limbs, with 61% more (95% confidence interval 50% to 72%) lower 
limb lesions in women than men. The overall median pain score was 4.6 (0-10cm). Women 
recorded higher pain scores than men (Figure 1A), p=0.009.  Although highly significant, the 
difference in pain by gender was moderate with women reporting a median of 1 cm (95% 
confidence interval 0.2 to 1.9) more pain than men, p=0.021, on univariate analysis. 
Pain increased as fluorescence increased (Figure 1B), p<0.0001. Fluorescence was 
however not a good predictor of pain, explaining only 3.6% of pain experienced (R-squared 
0.036). 
As with fluorescence, pain increased as erythema increased (Figure 1C), p=0.017.  Although 
significantly (a finding unlikely to be chance) associated with pain erythema only accounted 
for 3.3% of pain experienced (R-squared 0.033).   
Patient age, skin phototype, diagnosis, lesion site and size were not significantly associated 
with reported PDT-induced pain.  Most lesions were clear following PDT.  However, smaller 
lesions were more likely to clear (Figure 1D), p=0.002.  No association was found between 
any of the other variables examined and one-year clearance.  
Thus, female gender, strong fluorescence and erythema were associated with higher levels 
of reported PDT-induced pain.  However, these did not explain most of the pain experienced, 
highlighting that there are other factors involved. This emphasises the heterogeneous nature 
of PDT-induced pain and reinforces the diversity of factors involved and subjectivity of pain 
reporting. High clearance rates were achieved, particularly for smaller lesions.  Limitations of 
this study included its retrospective design and that data analysed were for each lesion’s first 
treatment, and analysis of all treatments may have been helpful to see if continued high 
rates of erythema/fluorescence were associated with increased pain during subsequent PDT 
treatments.  Furthermore, assessments of fluorescence and erythema were semi-
quantitative and based on visual grading, as opposed to more detailed objective 
measurements, which may have been more discriminating, but are not undertaken in routine 
practice. As clearance rates in this sample were so high it was difficult to analyse predictors 
of clearance as the number of lesions not cleared was small.  However, multivariate analysis 
used to minimise confounding variables’ impact in this retrospective study helped to 
differentiate which variables were most associated with pain and outcome.   
This analysis differentiates this study from others.3,5 For example, Grapengiesser and 
colleagues reported on PDT-induced pain in 60 patients (69 lesions) and showed, using 
univariate analyses that pain scores were higher in males, head and larger treatment sites 
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and actinic keratoses, but the authors also commented on the limitation that it tends to be 
males who have large areas of actinic keratosis on head and neck treated by PDT and thus 
it was not possible to define which factor was most influential because of these confounding 
influences.3 Furthermore, Virgili and colleagues investigated factors that may be implicated 
in PDT-induced pain in 121 Italian patients and whilst they too demonstrated higher pain 
scores at head and neck sites and for actinic keratosis, they did not show any clear overall 
impact of gender and again highlighted the limitations of their study, which involved 
univariate analysis of data.5   
Thus, in summary, we have attempted to minimise the impact of confounding factors through 
the use of multivariate analysis of data and to provide useful information for PDT 
practitioners and patients regarding possible predictors of PDT-induced pain and efficacy 
that may help to inform optimisation of treatment regimens. 
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